Home
Baselake Partners reported a 7.3% stake in Passage BIO PASG · 235,058 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 7.3%
- Last report
- First report
- Shares held
- 235,058 sh
- Class
- Common Stock, $0.0001 Par Value Per Share
- Stock
- Passage BIO PASG
- Holder
- Baselake Partners
- Event date
- 26/06/18
- Filed
- 26/06/25
First 5%+ report · 7.3% stake
Passage BIO trades, last 26 weeks
What else happened in Passage BIO around then
Filed or reported within 30 days of the trade day · 05/19~07/18Baselake Partners's other 5% stake reports
- Baselake Partners
5% stakeKiora Pharmaceuticals
5% stakeKiora Pharmaceuticals
KPRX
5.8% stake
257,500 sh
5.8% stake
Filed 09/17
- Baselake Partners
5% stakeTherapeuticsMD
5% stakeTherapeuticsMD
TXMD
6.8% stake
790,703 sh
6.8% stake
Filed 08/05
- Baselake Partners
5% stakeTherapeuticsMD
5% stakeTherapeuticsMD
TXMD
5.2% stake
607,181 sh
5.2% stake
Filed 04/06
- Baselake Partners
5% stakeLeonaBio
5% stakeLeonaBio
LONA
1.9% stake
75,789 sh
1.9% stake
Filed 02/06
- Baselake Partners
5% stakeNeuphoria Therapeutics
5% stakeNeuphoria Therapeutics
NEUP
4.1% stake
222,222 sh
4.1% stake
Filed 02/06
